Aprill Lane, US Advocacy Lead for Rare Disease at UCB, discusses a new national initiative aimed at improving nutrition access and reducing daily disease burden for patients with myasthenia gravis.
Aprill Lane
Advertisement
Articles by Aprill Lane
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts sNDAs for Casimersen and Golodirsen, Chris Johnson Diagnosed with ALS, Phase 2 Trial of NEU-411 Expands
2
NeurologyLive® Friday 5 — July 3, 2026
3
FDA Clears PoNS Device for Stroke Rehabilitation, Expanding Neurostimulation Beyond MS Indication
4
Where Tolebrutinib Fits: Weighing the EU Approval, FDA Divergence, and the Road Ahead in nrSPMS
5